Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04391660Phase 4Completed
Phase 4, randomised, open-label trial of sodium hypochlorite in catheter colonization and catheter-related bloodstream infection (CRBSI) (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Incidence of colonized catheters at 14 days. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04391660.